Status:
COMPLETED
Influence of Inotropic Choice on Morbidity and Mortality in Complex Pediatric Heart Surgery
Lead Sponsor:
Brugmann University Hospital
Collaborating Sponsors:
Queen Fabiola Children's University Hospital
Conditions:
Pediatric Cardiac Surgery
Eligibility:
All Genders
Up to 1 years
Brief Summary
Our study is based on the observation that management of the cardiopulmonary by-pass withdrawal in pediatric heart surgery is quite variable between medical teams. Indeed, in our center (HUDERF), the...
Detailed Description
As use of inotropes is highly variable between anesthesiologists, the investigators want to study if the choice of the inotropic drugs have an impact on morbid-mortality in paediatric cardiac surgery....
Eligibility Criteria
Inclusion
- Patient under 1 year old. Cardiac surgery with CPB between 2008-2018. RACHS-1 risk categories \>3.
- We selected the most relevant and common surgery in our center:
- Transposition of the great arteries
- Atrio-ventricular canal defect
- Aortic coarctation or interruption
- Truncus arteriosus
- Mitral valvuloplasty
Exclusion
- None
Key Trial Info
Start Date :
May 11 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 10 2020
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT04380181
Start Date
May 11 2020
End Date
June 10 2020
Last Update
June 11 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Universitaire des Enfants Reine Fabiola
Brussels, Belgium, 1020